APOL1 Mediated Kidney Diseases Market Size, Share, Growth Rate, Industry Analysis and Global Forecast - PowerPoint PPT Presentation

About This Presentation
Title:

APOL1 Mediated Kidney Diseases Market Size, Share, Growth Rate, Industry Analysis and Global Forecast

Description:

According to a latest report published by Future Market Insights (FMI), the global APOL1 mediated kidney disease market was valued at US$ 3.0 Bn in 2020 and is anticipated to witness a steady CAGR of over 4% during the forecast period (2020-2030). – PowerPoint PPT presentation

Number of Views:62
Slides: 11
Provided by: Umesh213
Category: Other

less

Transcript and Presenter's Notes

Title: APOL1 Mediated Kidney Diseases Market Size, Share, Growth Rate, Industry Analysis and Global Forecast


1

Renal Biomarker Market Report Competitive
Landscape Prediction And Industry Statistics
Analysis by 2026 FMI Report
  • April 2021

Report Id REP-GB-1731Published On
2016-11-22Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

SOLUTION
  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
4
Renal Biomarker Market Analysis
Biomarker is a measurable biological indicator of
the health status of an individual, especially of
one at the risk of developing or presence of a
particular disease. In the past, the term
'biomarker' referred to physiological traits,
however, with the advent of technologically
advanced diagnostic measures, biomarkers now
refer to products of metobolomic, genomic, and
proteomic research. Chronic kidney disease (CKD)
is a major risk multiplier for cardiovascular
disease, diabetes, hypertension, inflammatory
disease of kidney (glomerulonephritis), and
aging Future Market Insights delivers key
insights on the global renal biomarker market in
a new report titled Renal Biomarker Market
Global Industry Analysis and Opportunity
Assessment, 2016-2026. In terms of revenue, the
global renal biomarker market is projected to
register a healthy CAGR of 7.0 over the forecast
period. In this report, Future Market Insights
throws light on the various factors and trends
impacting market growth over the forecast period
(2016 2026). According to Future Market
Insights analysts, a rising prevalence of renal
diseases is likely to boost the growth of the
global renal biomarker market over the forecast
period. Other prominent growth factors include a
large number of clinical trials in the novel
renal biomarker and drug development space and
penetration of various cost-effective, reliable,
and rapid technologically driven diagnostic
protocols in clinical practice.
5
Renal Biomarker Market Analysis
However, use of unreliable imperfect gold
standard for renal disease diagnosis and lack of
sensitivity and specificity in current renal
biomarkers are some of the factors restraining
the growth of the market over the forecast
period. Request a Sample Report with Table of
Contents http//www.futuremarketinsights.com/repo
rts/sample/rep-gb-1731 A growing popularity of
non-invasive renal biomarkers could help
researchers in the development of studies
utilising urine biomarkers and tracking therapies
early in the course of diseases diagnosis.
Additionally, formation of several consortiums on
renal disease accelerating RD involves
investigators from multiple institutions working
together to pursue the discovery and validation
of novel biomarkers to advance the field of renal
biomarker research. Segmentation highlights The
global renal biomarker market is segmented on the
basis of Biomarker Type (Functional Biomarker,
Up-Regulated Proteins, Others) Diagnostic
Technique (Enzyme Linked Immunosorbent Assay,
Particle-Enhanced Turbidimetric Immunoassay,
Colorimetric Assay, Chemiluminescent Enzyme
Immunoassay, Liquid Chromatography-Mass
Spectrometry) and End User (Diagnostic Labs,
Outpatient Clinics, Research Centres, Hospitals).
6
Renal Biomarker Market Analysis
  • The Functional Biomarker type segment is
    anticipated to be valued at US 471.2 Mn by the
    end of 2016, registering a CAGR of 7.6 over the
    forecast period. The Up-Regulated Proteins type
    segment is estimated to create absolute
    opportunity of US 19.5 Mn in 2017 over 2016
  • The Enzyme Linked Immunosorbent Assay diagnostic
    technique segment is expected to register high
    Y-o-Y growth rates throughout the forecast period
    and is anticipated to reach a market valuation of
    US 390.9 Mn by the end of 2016. The
    Particle-Enhanced Turbidimetric Immunoassay
    diagnostic technique segment is estimated to
    register a CAGR of 7.0 over the forecast period
  • The Diagnostic Labs end user segment is
    anticipated to reach a market value share of US
    308.4 Mn by the end of 2016. The Outpatient
    Clinics end user segment is estimated to hold a
    market value share of 30.1 by the end of 2016,
    making it the second highest end user growth
    segment of the global renal biomarker market

7
Renal Biomarker Market Analysis
Preview Analysis on Global Renal Biomarker Market
Segmentation By Biomarker Type Functional
Biomarker, Serum Creatinine, Serum Cystatin C,
Urine Albumin, Up-Regulated Proteins, Neutrophil
Gelatinase-Associated Lipocalin, Kidney Injury
Molecule 1 and Interleukin 18, By Diagnostic
Technique Enzyme Linked Immunosorbent Assay,
Particle-Enhanced Turbidimetric Immunoassay,
Colorimetric Assay, Chemiluminescent Enzyme
Immunoassay and Liquid Chromatography-Mass
Spectrometry, By End User Diagnostic Labs and
Outpatient Clinics https//www.futuremarketinsigh
ts.com/checkout/1731 Regional analysis The
global renal biomarker market is segmented into
the seven key regions of North America, Latin
America, Western Europe, Eastern Europe, Asia
Pacific Excluding Japan (APEJ), Japan, and Middle
East Africa (MEA). The North America renal
biomarker market is expected to register high
Y-o-Y growth throughout the forecast period. The
market in this region is anticipated to witness a
CAGR of 7.6 over the forecast period. The
presence of leading renal biomarker manufacturers
and established distribution channels in North
America is expected to create significant growth
opportunities over the next 10 years. The Western
Europe renal biomarker market is estimated to
represent absolute opportunity of US 14.1 Mn
in 2017 over 2016.
8
Renal Biomarker Market Analysis
  • Vendor insights
  • The global renal biomarker market report profiles
    some of the top companies operating in the global
    market. Leading market players featured in the
    report include Beckman Coulter, Inc. (Danaher
    Corporation), Thermo Fisher Scientific Inc.,
    Abbott Laboratories, BIOPORTO A/S, Astute
    Medical, Inc., and Randox Laboratories Ltd. The
    report discusses individual strategies adopted by
    these companies in terms of enhancing product
    designing, creating new manufacturing facilities,
    market consolidation, and advanced RD
    initiatives.
  • Market segmentation
  • By Diagnostic Technique
  • Enzyme Linked Immunosorbent Assay
  • Particle-Enhanced Turbidimetric Immunoassay
  • Colorimetric Assay
  • Chemiluminescent Enzyme Immunoassay
  • Liquid Chromatography-Mass Spectrometry

Speak with Analyst for any Report Related
Querieshttp//www.futuremarketinsights.com/askus/
rep-gb-1731
9
Renal Biomarker Market Analysis
  • By Region
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • Middle East Africa (MEA)
  • By Biomarker Type
  • Functional Biomarker
  • Serum Creatinine
  • Serum Cystatin C
  • Urine Albumin
  • Up-Regulated Proteins
  • Neutrophil gelatinase-associated lipocalin
  • Kidney injury molecule 1
  • Interleukin 18
  • Others

Request for covid19 Impact Analysis
_at_ https//www.futuremarketinsights.com/covid19/rep
-gb-1731
10
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
Write a Comment
User Comments (0)
About PowerShow.com